Cargando…
Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
SIMPLE SUMMARY: Transarterial chemoembolization (TACE) is the treatment of choice for patients with liver cancer without distant metastases or tumor growth into blood vessels. For the latter patients, sorafenib is a well-established oral medication. Combination of both treatments might also enhance...
Autores principales: | Koch, Christine, Göller, Markus, Schott, Eckart, Waidmann, Oliver, op den Winkel, Mark, Paprottka, Philipp, Zangos, Stephan, Vogl, Thomas, Bechstein, Wolf Otto, Zeuzem, Stefan, Kolligs, Frank T., Trojan, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124282/ https://www.ncbi.nlm.nih.gov/pubmed/33924810 http://dx.doi.org/10.3390/cancers13092121 |
Ejemplares similares
-
Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma
por: Schrecker, Christopher, et al.
Publicado: (2022) -
Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014) -
Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020) -
Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis
por: Schulz, Martin S., et al.
Publicado: (2022) -
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
por: Ha, Yeonjung, et al.
Publicado: (2016)